Deep Learning Reconstruction of Prospectively Accelerated MRI of the Pancreas: Clinical Evaluation of Shortened Breath-Hold Examinations With Dixon Fat Suppression.

OBJECTIVE

Deep learning (DL)-enabled magnetic resonance imaging (MRI) reconstructions can enable shortening of breath-hold examinations and improve image quality by reducing motion artifacts. Prospective studies with DL reconstructions of accelerated MRI of the upper abdomen in the context of pancreatic pathologies are lacking. In a clinical setting, the purpose of this study is to investigate the performance of a novel DL-based reconstruction algorithm in T1-weighted volumetric interpolated breath-hold examinations with partial Fourier sampling and Dixon fat suppression (hereafter, VIBE-Dixon DL ). The objective is to analyze its impact on acquisition time, image sharpness and quality, diagnostic confidence, pancreatic lesion conspicuity, signal-to-noise ratio (SNR), and contrast-to-noise ratio (CNR).

METHODS

This prospective single-center study included participants with various pancreatic pathologies who gave written consent from January 2023 to September 2023. During the same session, each participant underwent 2 MRI acquisitions using a 1.5 T scanner: conventional precontrast and postcontrast T1-weighted VIBE acquisitions with Dixon fat suppression (VIBE-Dixon, reference standard) using 4-fold parallel imaging acceleration and 6-fold accelerated VIBE-Dixon acquisitions with partial Fourier sampling utilizing a novel DL reconstruction tailored to the acquisition. A qualitative image analysis was performed by 4 readers. Acquisition time, image sharpness, overall image quality, image noise and artifacts, diagnostic confidence, as well as pancreatic lesion conspicuity and size were compared. Furthermore, a quantitative analysis of SNR and CNR was performed.

RESULTS

Thirty-two participants were evaluated (mean age ± SD, 62 ± 19 years; 20 men). The VIBE-Dixon DL method enabled up to 52% reduction in average breath-hold time (7 seconds for VIBE-Dixon DL vs 15 seconds for VIBE-Dixon, P < 0.001). A significant improvement of image sharpness, overall image quality, diagnostic confidence, and pancreatic lesion conspicuity was observed in the images recorded using VIBE-Dixon DL ( P < 0.001). Furthermore, a significant reduction of image noise and motion artifacts was noted in the images recorded using the VIBE-Dixon DL technique ( P < 0.001). In addition, for all readers, there was no evidence of a difference in lesion size measurement between VIBE-Dixon and VIBE-Dixon DL . Interreader agreement between VIBE-Dixon and VIBE-Dixon DL regarding lesion size was excellent (intraclass correlation coefficient, >90). Finally, a statistically significant increase of pancreatic SNR in VIBE-DIXON DL was observed in both the precontrast ( P = 0.025) and postcontrast images ( P < 0.001). Also, an increase of splenic SNR in VIBE-DIXON DL was observed in both the precontrast and postcontrast images, but only reaching statistical significance in the postcontrast images ( P = 0.34 and P = 0.003, respectively). Similarly, an increase of pancreas CNR in VIBE-DIXON DL was observed in both the precontrast and postcontrast images, but only reaching statistical significance in the postcontrast images ( P = 0.557 and P = 0.026, respectively).

CONCLUSIONS

The prospectively accelerated, DL-enhanced VIBE with Dixon fat suppression was clinically feasible. It enabled a 52% reduction in breath-hold time and provided superior image quality, diagnostic confidence, and pancreatic lesion conspicuity. This technique might be especially useful for patients with limited breath-hold capacity.